Skip to main content
. 2022 Aug 8;28(9):1840–1847. doi: 10.1038/s41591-022-01935-8

Fig. 3.

Fig. 3

Kaplan–Meier plot showing progression-free survival times (months) in the TUXEDO-1 trial.